Skip to main content
Top
Published in: Inflammation 6/2013

01-12-2013

Diet and Diet Combined with Chronic Aerobic Exercise Decreases Body Fat Mass and Alters Plasma and Adipose Tissue Inflammatory Markers in Obese Women

Authors: Nadia Lakhdar, Myriam Denguezli, Monia Zaouali, Abdelkrim Zbidi, Zouhair Tabka, Anissa Bouassida

Published in: Inflammation | Issue 6/2013

Login to get access

Abstract

The purpose of this study was to investigate the effect of 6 months aerobic exercise and diet alone or in combination on markers of inflammation (MOI) in circulation and in adipose abdominal tissue (AT) in obese women. Thirty obese subjects were randomized into a 24-week intervention: (1) exercise (EX), (2) diet (DI), and (3) exercise and diet (EXD). Blood samples were collected at baseline, after 12 and 24 weeks. AT biopsies were obtained only at baseline and after 24 weeks. In the EXD and DI groups, the fat loss was after 12 weeks was −13.74 and −7.8 % (P < 0.01) and after 24 weeks was −21.82 and −17 % (P < 0.01) with no changes in the EX group. After 12 and 24 weeks, maximal oxygen consumption (VO2max) was increased by 21.81–39.54 % (P < 0.05) in the EXD group and 18.09–40.95 % in the EX group with no changes in the DI group. In the EXD and DI groups, circulating levels of tumor necrosis factor α and interleukin 6 were decreased after 24 weeks for both groups (P < 0.01). No changes in the EX group. Homeostatic model assessment for insulin resistance decreased (P < 0.05) only after 24 weeks in the EXD group. In AT biopsies, subjects in the EXD and DI groups exhibited a significant decrease in MO (P < 0.01 for all). No changes in AT biopsies were found in the EX group. In conclusion, chronic aerobic exercise was found to have no effects on circulating and AT MOI despite an increased VO2max. Rather important body composition modifications were found to have beneficial effects on circulating and AT MOI in these obese women.
Literature
1.
go back to reference Catenacci, V.A., J.O. Hill, and H.R. Wyatt. 2009. The obesity epidemic. Clinics in Chest Medicine 30: 415–444.PubMedCrossRef Catenacci, V.A., J.O. Hill, and H.R. Wyatt. 2009. The obesity epidemic. Clinics in Chest Medicine 30: 415–444.PubMedCrossRef
2.
go back to reference de Ferranti, S., and D. Mozaffarian. 2008. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clinical Chemistry 54: 945–955.PubMedCrossRef de Ferranti, S., and D. Mozaffarian. 2008. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clinical Chemistry 54: 945–955.PubMedCrossRef
3.
go back to reference Nicklas, B.J., T. You, and M. Pahor. 2005. Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. Canadian Medical Association Journal 172(9): 1199–1209.PubMedCrossRef Nicklas, B.J., T. You, and M. Pahor. 2005. Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. Canadian Medical Association Journal 172(9): 1199–1209.PubMedCrossRef
4.
go back to reference Belobrajdic, D.P., J. Frystyk, N. Jeyaratnaganthan, U. Espelund, A. Flyvbjerg, P.M. Clifton, and M. Noakes. 2010. Moderate energy restriction-induced weight loss affects circulating IGF levels independent of dietary composition. European Journal of Endocrinology 162(6): 1075–1082.PubMedCrossRef Belobrajdic, D.P., J. Frystyk, N. Jeyaratnaganthan, U. Espelund, A. Flyvbjerg, P.M. Clifton, and M. Noakes. 2010. Moderate energy restriction-induced weight loss affects circulating IGF levels independent of dietary composition. European Journal of Endocrinology 162(6): 1075–1082.PubMedCrossRef
5.
go back to reference Campbell, K.L., K.E. Foster-Schubert, K.W. Makar, M. Kratz, D. Hagman, E. Schur, N. Habermann, M. Horton, C. Abbenhardt, L.Y. Kuan, L. Xiao, J. Davison, M. Morgan, C.Y. Wang, C. Duggan, A. McTiernan, and C.M. Ulrich. 2013. Gene expression changes in adipose tissue with diet- and/or exercise-induced weight loss. Cancer Prevention Research 6(3): 217–231.PubMedCrossRef Campbell, K.L., K.E. Foster-Schubert, K.W. Makar, M. Kratz, D. Hagman, E. Schur, N. Habermann, M. Horton, C. Abbenhardt, L.Y. Kuan, L. Xiao, J. Davison, M. Morgan, C.Y. Wang, C. Duggan, A. McTiernan, and C.M. Ulrich. 2013. Gene expression changes in adipose tissue with diet- and/or exercise-induced weight loss. Cancer Prevention Research 6(3): 217–231.PubMedCrossRef
6.
go back to reference Ogawa, K., K. Sanada, S. Machida, M. Okutsu, and K. Suzuki. 2010. Resistance exercise training-induced muscle hypertrophy was associated with reduction of inflammatory markers in elderly women. Mediators of Inflammation. doi:10.1155/2010/171023.PubMed Ogawa, K., K. Sanada, S. Machida, M. Okutsu, and K. Suzuki. 2010. Resistance exercise training-induced muscle hypertrophy was associated with reduction of inflammatory markers in elderly women. Mediators of Inflammation. doi:10.​1155/​2010/​171023.PubMed
7.
go back to reference Fisher, G., G.R. Hunter, and B.A. Gower. 2012. Aerobic exercise training conserves insulin sensitivity for 1 yr following weight loss in overweight women. Journal of Applied Physiology 112(4): 688–693.PubMedCrossRef Fisher, G., G.R. Hunter, and B.A. Gower. 2012. Aerobic exercise training conserves insulin sensitivity for 1 yr following weight loss in overweight women. Journal of Applied Physiology 112(4): 688–693.PubMedCrossRef
8.
go back to reference Petersen, A.M., and B.K. Pedersen. 2005. The anti-inflammatory effect of exercise. Journal of Applied Physiology 98: 1154–1162.PubMedCrossRef Petersen, A.M., and B.K. Pedersen. 2005. The anti-inflammatory effect of exercise. Journal of Applied Physiology 98: 1154–1162.PubMedCrossRef
9.
go back to reference Thompson, D., D. Markovitch, J.A. Betts, D. Mazzatti, J. Turner, and R.M. Tyrrell. 2010. Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial. Journal of Applied Physiology 108(4): 769–779.PubMedCrossRef Thompson, D., D. Markovitch, J.A. Betts, D. Mazzatti, J. Turner, and R.M. Tyrrell. 2010. Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial. Journal of Applied Physiology 108(4): 769–779.PubMedCrossRef
10.
go back to reference Nicklas, B.J., W. Ambrosius, S.P. Messier, G.D. Miller, B.W. Penninx, R.F. Loeser, S. Palla, E. Bleecker, and M. Pahor. 2004. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. American Journal of Clinical Nutrition 79(4): 544–551.PubMed Nicklas, B.J., W. Ambrosius, S.P. Messier, G.D. Miller, B.W. Penninx, R.F. Loeser, S. Palla, E. Bleecker, and M. Pahor. 2004. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. American Journal of Clinical Nutrition 79(4): 544–551.PubMed
11.
go back to reference Nicklas, B.J., F.C. Hsu, T.J. Brinkley, T. Church, B.H. Goodpaster, S.B. Kritchevsky, and M. Pahor. 2008. Exercise training and plasma C-reactive protein and interleukin-6 in elderly people. Journal of the American Geriatrics Society 56(11): 2045–2052.PubMedCrossRef Nicklas, B.J., F.C. Hsu, T.J. Brinkley, T. Church, B.H. Goodpaster, S.B. Kritchevsky, and M. Pahor. 2008. Exercise training and plasma C-reactive protein and interleukin-6 in elderly people. Journal of the American Geriatrics Society 56(11): 2045–2052.PubMedCrossRef
12.
go back to reference Christiansen, T., S.K. Paulsen, J.M. Bruun, S.B. Pedersen, and B. Richelsen. 2010. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. American Journal of Physiology, Endocrinology and Metabolism 298(4): E824–E831.CrossRef Christiansen, T., S.K. Paulsen, J.M. Bruun, S.B. Pedersen, and B. Richelsen. 2010. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. American Journal of Physiology, Endocrinology and Metabolism 298(4): E824–E831.CrossRef
13.
go back to reference Leggate, M., W.G. Carter, M.J. Evans, R.A. Vennard, S. Sribala-Sundaram, and M.A. Nimmo. 2012. Determination of inflammatory and prominent proteomic changes in plasma and adipose tissue after high-intensity intermittent training in overweight and obese males. Journal of Applied Physiology 112(8): 1353–1360.PubMedCrossRef Leggate, M., W.G. Carter, M.J. Evans, R.A. Vennard, S. Sribala-Sundaram, and M.A. Nimmo. 2012. Determination of inflammatory and prominent proteomic changes in plasma and adipose tissue after high-intensity intermittent training in overweight and obese males. Journal of Applied Physiology 112(8): 1353–1360.PubMedCrossRef
14.
go back to reference Wasserman, K., J.E. Hansen, D.Y. Sue, and B.J. Whipp. 1987. Principles of exercise testing and interpretation. Philadelphia: Lea & Febiger. 73. Wasserman, K., J.E. Hansen, D.Y. Sue, and B.J. Whipp. 1987. Principles of exercise testing and interpretation. Philadelphia: Lea & Febiger. 73.
15.
go back to reference Tanaka, H., K.D. Monahan, and D.R. Seals. 2001. Age-predicted maximal heart rate revisited. Journal of the American College of Cardiology 37: 153–156.PubMedCrossRef Tanaka, H., K.D. Monahan, and D.R. Seals. 2001. Age-predicted maximal heart rate revisited. Journal of the American College of Cardiology 37: 153–156.PubMedCrossRef
16.
go back to reference Matthews, D.R., J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419.PubMedCrossRef Matthews, D.R., J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419.PubMedCrossRef
17.
go back to reference Madsen, E.L., A. Rissanen, J.M. Bruun, K. Skogstrand, S. Tonstad, D.M. Hougaard, and B. Richelsen. 2008. Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. European Journal of Endocrinology 158: 179–187.PubMedCrossRef Madsen, E.L., A. Rissanen, J.M. Bruun, K. Skogstrand, S. Tonstad, D.M. Hougaard, and B. Richelsen. 2008. Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. European Journal of Endocrinology 158: 179–187.PubMedCrossRef
18.
go back to reference Córdova, C., F. Lopes-E-Silva Jr., A.S. Pires, V.C. Souza, C.J. Brito, C.F. Moraes, A.C. Sposito, and O.T. Nóbrega. 2011. Long-term resistance training is associated with reduced circulating levels of IL-6, IFN-γ and TNF-α in elderly women. Neuroimmunomodulation 18(3): 165–170.PubMedCrossRef Córdova, C., F. Lopes-E-Silva Jr., A.S. Pires, V.C. Souza, C.J. Brito, C.F. Moraes, A.C. Sposito, and O.T. Nóbrega. 2011. Long-term resistance training is associated with reduced circulating levels of IL-6, IFN-γ and TNF-α in elderly women. Neuroimmunomodulation 18(3): 165–170.PubMedCrossRef
19.
go back to reference Ho, S.S., S.S. Dhaliwal, A.P. Hills, and S. Pal. 2012. Effects of chronic exercise training on inflammatory markers in Australian overweight and obese individuals in a randomized controlled trial. Inflammation(Dec 19). Ho, S.S., S.S. Dhaliwal, A.P. Hills, and S. Pal. 2012. Effects of chronic exercise training on inflammatory markers in Australian overweight and obese individuals in a randomized controlled trial. Inflammation(Dec 19).
20.
go back to reference Libardi, C.A., G.V. De Souza, C.R. Cavaglieri, V.A. Madruga, and M.P. Chacon-Mikahil. 2012. Effect of resistance, endurance, and concurrent training on TNF-α, IL-6, and CRP. Medicine and Science in Sports and Exercise 44(1): 50–56.PubMedCrossRef Libardi, C.A., G.V. De Souza, C.R. Cavaglieri, V.A. Madruga, and M.P. Chacon-Mikahil. 2012. Effect of resistance, endurance, and concurrent training on TNF-α, IL-6, and CRP. Medicine and Science in Sports and Exercise 44(1): 50–56.PubMedCrossRef
21.
go back to reference Tisi, P.V., M. Hulse, A. Chulakadabba, P. Gosling, and C.P. Shearman. 1997. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? European Journal of Vascular and Endovascular Surgery 14: 344–350.PubMedCrossRef Tisi, P.V., M. Hulse, A. Chulakadabba, P. Gosling, and C.P. Shearman. 1997. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? European Journal of Vascular and Endovascular Surgery 14: 344–350.PubMedCrossRef
22.
go back to reference Hammett, C.J., H.C. Oxenham, J.C. Baldi, R.N. Doughty, R. Ameratunga, J.K. French, H.D. White, and R.A. Stewart. 2004. Effect of six months’ exercise training on C-reactive rotein levels in healthy elderly subjects. Journal of the American College of Cardiology 44: 2411–2413.PubMedCrossRef Hammett, C.J., H.C. Oxenham, J.C. Baldi, R.N. Doughty, R. Ameratunga, J.K. French, H.D. White, and R.A. Stewart. 2004. Effect of six months’ exercise training on C-reactive rotein levels in healthy elderly subjects. Journal of the American College of Cardiology 44: 2411–2413.PubMedCrossRef
23.
go back to reference Huffman, K.M., C.A. Slentz, C.W. Bales, J.A. Houmard, and W.E. Kraus. 2008. Relationships between adipose tissue and cytokine responses to a randomized controlled exercise training intervention. Metabolism 57(4): 577–583.PubMedCrossRef Huffman, K.M., C.A. Slentz, C.W. Bales, J.A. Houmard, and W.E. Kraus. 2008. Relationships between adipose tissue and cytokine responses to a randomized controlled exercise training intervention. Metabolism 57(4): 577–583.PubMedCrossRef
24.
go back to reference Karastergiou, K., and V. Mohamed-Ali. 2010. The autocrine and paracrine roles of adipokines. Molecular and Cellular Endocrinology 318: 69–78.PubMedCrossRef Karastergiou, K., and V. Mohamed-Ali. 2010. The autocrine and paracrine roles of adipokines. Molecular and Cellular Endocrinology 318: 69–78.PubMedCrossRef
25.
go back to reference Rotter, V., I. Nagaev, and U. Smith. 2003. Interleukin-6 (IL-6) induces insulin resistance in 3T3–L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. Journal of Biological Chemistry 278: 45777–45784.PubMedCrossRef Rotter, V., I. Nagaev, and U. Smith. 2003. Interleukin-6 (IL-6) induces insulin resistance in 3T3–L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. Journal of Biological Chemistry 278: 45777–45784.PubMedCrossRef
26.
go back to reference Lagathu, C., J.P. Bastard, M. Auclair, M. Maachi, J. Capeau, and M. Caron. 2003. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochemical and Biophysical Research Communications 311: 372–379.PubMedCrossRef Lagathu, C., J.P. Bastard, M. Auclair, M. Maachi, J. Capeau, and M. Caron. 2003. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochemical and Biophysical Research Communications 311: 372–379.PubMedCrossRef
27.
go back to reference Hotamisligil, G.S. 2003. Inflammatory pathways and insulin action. International Journal of Obesity and Related Metabolic Disorders 27(Suppl 3): S53–S55.PubMedCrossRef Hotamisligil, G.S. 2003. Inflammatory pathways and insulin action. International Journal of Obesity and Related Metabolic Disorders 27(Suppl 3): S53–S55.PubMedCrossRef
28.
go back to reference Perseghin, G., K. Petersen, and G.I. Shulman. 2003. Cellular mechanism of insulin resistance: potential links with inflammation. International Journal of Obesity and Related Metabolic Disorders 27(Suppl 3): S6–S11.PubMedCrossRef Perseghin, G., K. Petersen, and G.I. Shulman. 2003. Cellular mechanism of insulin resistance: potential links with inflammation. International Journal of Obesity and Related Metabolic Disorders 27(Suppl 3): S6–S11.PubMedCrossRef
29.
go back to reference Swaroop, J.J., D. Rajarajeswari, and J.N. Naidu. 2012. Association of TNF-α with insulin resistance in type 2 diabetes mellitus. Indian Journal of Medical Research 135: 127–130.PubMedCrossRef Swaroop, J.J., D. Rajarajeswari, and J.N. Naidu. 2012. Association of TNF-α with insulin resistance in type 2 diabetes mellitus. Indian Journal of Medical Research 135: 127–130.PubMedCrossRef
30.
go back to reference Kelly, K.R., J.M. Haus, T.P. Solomon, A.J. Patrick-Melin, M. Cook, M. Rocco, H. Barkoukis, and J.P. Kirwan. 2011. A low-glycemic index diet and exercise intervention reduces TNF(alpha) in isolated mononuclear cells of older, obese adults. Journal of Nutrition 141(6): 1089–1094.PubMedCrossRef Kelly, K.R., J.M. Haus, T.P. Solomon, A.J. Patrick-Melin, M. Cook, M. Rocco, H. Barkoukis, and J.P. Kirwan. 2011. A low-glycemic index diet and exercise intervention reduces TNF(alpha) in isolated mononuclear cells of older, obese adults. Journal of Nutrition 141(6): 1089–1094.PubMedCrossRef
31.
go back to reference Mohamed-Ali, V., S. Goodrick, A. Rawesh, D.R. Katz, J.M. Miles, J.S. Yudkin, S. Klein, and S.W. Coppack. 1997. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. The Journal of Clinical Endocrinology and Metabolism 82: 4196–4200.PubMedCrossRef Mohamed-Ali, V., S. Goodrick, A. Rawesh, D.R. Katz, J.M. Miles, J.S. Yudkin, S. Klein, and S.W. Coppack. 1997. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. The Journal of Clinical Endocrinology and Metabolism 82: 4196–4200.PubMedCrossRef
32.
go back to reference Fain, J.N., A.K. Madan, M.L. Hiler, P. Cheema, and S.W. Bahouth. 2004. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145: 2273–2282.PubMedCrossRef Fain, J.N., A.K. Madan, M.L. Hiler, P. Cheema, and S.W. Bahouth. 2004. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145: 2273–2282.PubMedCrossRef
33.
go back to reference Cancello, R., C. Henegar, N. Viguerie, S. Taleb, C. Poitou, C. Rouault, M. Coupaye, V. Pelloux, D. Hugol, J.L. Bouillot, A. Bouloumié, G. Barbatelli, S. Cinti, P.A. Svensson, G.S. Barsh, J.D. Zucker, A. Basdevant, D. Langin, and K. Clément. 2005. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54: 2277–2286.PubMedCrossRef Cancello, R., C. Henegar, N. Viguerie, S. Taleb, C. Poitou, C. Rouault, M. Coupaye, V. Pelloux, D. Hugol, J.L. Bouillot, A. Bouloumié, G. Barbatelli, S. Cinti, P.A. Svensson, G.S. Barsh, J.D. Zucker, A. Basdevant, D. Langin, and K. Clément. 2005. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54: 2277–2286.PubMedCrossRef
Metadata
Title
Diet and Diet Combined with Chronic Aerobic Exercise Decreases Body Fat Mass and Alters Plasma and Adipose Tissue Inflammatory Markers in Obese Women
Authors
Nadia Lakhdar
Myriam Denguezli
Monia Zaouali
Abdelkrim Zbidi
Zouhair Tabka
Anissa Bouassida
Publication date
01-12-2013
Publisher
Springer US
Published in
Inflammation / Issue 6/2013
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9661-8

Other articles of this Issue 6/2013

Inflammation 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine